MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 7, 2023 Post category: Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 6, 2023 Post category: Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement Post author:GHIAA Admin Post published:March 3, 2023 Post category: Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement
National Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement Post author:GHIAA Admin Post published:March 2, 2023 Post category: Continue ReadingNational Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement
FIND Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 7, 2022 Post category: Continue ReadingFIND Sample Funding Terms and Conditions
UnitaidExplore Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 1, 2022 Post category: Continue ReadingUnitaidExplore Sample Funding Terms and Conditions
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 8, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement
DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 26, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 13, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement